Targeting dendritic cells with antigen-containing liposomes: antitumour immunity (Q35925604)

11 August 2017

1 reference

title

Targeting dendritic cells with antigen-containing liposomes: antitumour immunity (English)

1 reference

11 August 2017

1 reference

Joseph G Altin

1 reference

11 August 2017

Christina L van Broekhoven

series ordinal

1 reference

11 August 2017

Christopher R Parish

series ordinal

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Expert Opinion on Biological Therapy

11 August 2017

published in

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

page(s)

1735-1747

1 reference

Dendritic cells and the control of immunity

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Immunotherapy of cancer with dendritic-cell-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Dendritic cell biology and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Dendritic cells: immunobiology and cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Dendritic cells as vectors for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Dendritic cells in tumor immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Biophysical aspects of using liposomes as delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Liposomal delivery of CTL epitopes to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Liposomal delivery of antigen to human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Tumor-associated antigens: from discovery to immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Phagocytosis of antigens by Langerhans cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

DC-SIGN and LFA-1: a battle for ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Endogenous ligands of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

The immunobiology of the TLR9 subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Danger signals: a time and space continuum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Pattern recognition receptors: doubling up for the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Cancer immunotherapy and heat-shock proteins: promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Immune tolerance after delivery of dying cells to dendritic cells in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Anergic T cells as active regulators of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

T cell anergy and costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

The role of surface charge and hydrophilic groups on liposome clearance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Lipid composition is important for highly efficient target binding and retention of immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Liposomes as carriers of antigens and adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

The immunological adjuvant and vaccine carrier properties of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

ISCOM based vaccines for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Liposome-mediated cytoplasmic delivery of proteins: an effective means of accessing the MHC class I-restricted antigen presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

New tools for antigen delivery to the MHC class I pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

The development of IL-2 conjugated liposomes for therapeutic purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Role of transfection in the priming of cytotoxic T-cells by DNA-mediated immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

An overview of current delivery systems in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Gene delivery to dendritic cells facilitated by a tumor necrosis factor alpha-competing peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

The processing of antigens delivered as DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

A novel system for convenient detection of low-affinity receptor-ligand interactions: chelator-lipid liposomes engrafted with recombinant CD4 bind to cells expressing MHC class II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Synthesis of an amphiphilic tetraantennary mannosyl conjugate and incorporation into liposome carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Synthesis of the chelator lipid nitrilotriacetic acid ditetradecylamine (NTA-DTDA) and its use with the IAsys biosensor to study receptor-ligand interactions on model membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

Degradation of the tumor antigen epitope gp100(280-288) by fibroblast-associated enzymes abolishes specific immunorecognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1735

10.1517/14712598.4.11.1735

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference